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Abstract 
Background: Contrary to the increasing incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), 
GEP-NETs of the accessory papilla of the duodenum are extremely rare. Furthermore, there have been no recommen-
dations regarding the treatment strategy for GEP-NETs of the accessory papilla of the duodenum. We present a case 
of GEP-NET of the accessory papilla of the duodenum successfully treated with robotic pancreatoduodenectomy.
Case presentation: A case of a 70-year-old complaining of no symptoms was diagnosed with GEP-NET of the acces-
sory papilla of the duodenum. A 8-mm tumor was located at the submucosal layer with a biopsy demonstrating a 
neuroendocrine tumor grade 1. The patient underwent robotic pancreatoduodenectomy as curative resection for 
the tumor. The total operative time was 406 min with an estimated blood loss of 150 mL. The histological examina-
tion revealed a well-differentiated neuroendocrine tumor with low Ki-67 index (< 1%). In the posterior areas of the 
pancreas, the lymph node metastases were detected. The patient was followed up for 6 months with no recurrence 
postoperatively.
Conclusions: Considering the potential risks of the lymph node metastases, the standard treatment strategy for GEP-
NETs of the accessory papilla of the duodenum should be radical resection with pancreatoduodenectomy. Minimally 
invasive approach can be the alternative to the conventional open surgery.
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Background
Although the incidence of gastroenteropancreatic neu-
roendocrine tumors (GEP-NETs) has increased, GEP-
NETs of the duodenum are rare [1, 2]. Furthermore, 
GEP-NETs of the accessory papilla of the duodenum 
are extremely rare. To date, there have been only nine 
cases of GEP-NETs of the accessory papilla of the duo-
denum reported in the English literature [3–11]. We 
hereby present a case of GEP-NET of the accessory 
papilla of the duodenum successfully treated with robotic 
pancreatoduodenectomy.
Case presentation
A 70-year-old man was referred to our hospital for fur-
ther examination of a tumor at the duodenum. Esophago-
gastroduodenoscopy identified a submucosal tumor at 
the accessory papilla in the second part of the duodenum 
(Fig. 1a, b). Endoscopic ultrasonography showed a 8-mm 
hypoechoic mass in the submucosal layer (Fig.  1c), and 
endoscopic biopsy demonstrated a well-differentiated 
neuroendocrine tumor with a low Ki-67 index suggest-
ing grade 1 (G1). Computed tomography (CT) revealed 
a highly enhanced tumor in the early phase, showing 
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neither apparent lymph node metastases nor distant 
metastases (Fig. 1d). Magnetic resonance imaging (MRI) 
also detected no lymph node and liver metastases.
Although there have been no recommendations 
regarding the treatment strategy for GEP-NETs of the 
accessory papilla of the duodenum, radical resection with 
pancreatoduodenectomy has been recommended as the 
first-line treatment for GEP-NETs of the ampulla of Vater 
due to relatively poor prognosis [12]. Furthermore, endo-
scopic intervention was considered to be difficult due to 
the potential risk of the proper muscular layer damage of 
the duodenum as well as location at the accessory papilla. 
Therefore robotic pancreatoduodenectomy with lymph 
node dissection was performed.
Our standardized protocol for robotic pancreatoduo-
denectomy was previously reported [13]. Following the 
kocherization of the duodenum, the jejunum and the 
stomach are divided. The hepatoduodenal ligament was 
dissected to perform hilar lymphadenectomy. After the 
transection of the pancreas on the superior mesenteric 
vein, the uncinate dissection was performed along the 
superior mesenteric artery. Thereafter the specimen 
was removed through the Pfannenstiel incision. The 
reconstruction included the pancreaticojejunostomy 
with interrupted two-layer modified Blumgart method, 
the hepaticojejunostomy with interrupted sutures, 
and the gastrojejunostomy with the robotic-sewn 
anastomosis.
The total operative time was 406  min, and the esti-
mated blood loss was 150  mL. Uneventful postopera-
tive course including no complications was observed 
with the patient being discharged on postoperative day 
8. The final histological diagnosis was neuroendocrine 
tumor G1 based on the findings of synaptophysin posi-
tive, chromogranin A positive, and Ki-67 index (< 1%) 
(Fig.  2). The presence of lymphovascular invasion was 
not found in the D2-40 immunostaining. Surprisingly, 
the lymph node metastases were confirmed at posterior 
areas of the pancreas (station 13). Regarding immuno-
histochemical staining of endocrine cells, the insulin-, 
gastrin- and somatostatin-immunoreactive endocrine 
cells were not detected.
The patient was followed up for 6 months without 
recurrence postoperatively.
Fig. 1 Endoscopic examination showed a 8-mm submucosal tumor at the accessory papilla in the second part of the duodenum (a). The 
relationship between the tumor, the accessory papilla and the ampulla of Vater is demonstrated (b). Endoscopic ultrasonography demonstrated 
hypoechoic mass in the submucosal layer (c). Computed tomography (CT) revealed the highly enhanced tumor in the early phase with no 
metastatic lesion including the lymph node and the liver (d)
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Discussion
To our knowledge, this is the first description on GEP-
NETs of the accessory papilla of the duodenum with 
lymph node metastases successfully treated with robotic 
pancreatoduodenectomy. The present case indicates that 
a well-differentiated neuroendocrine tumor G1 with less 
than 1 cm at the accessory papilla of the duodenum could 
have the potential risks of the lymph node metastases. 
Therefore we suggest that radical surgical resection with 
pancreatoduodenectomy instead of local excision should 
be the first-line treatment option for GEP-NETs of the 
accessory papilla of the duodenum.
Contrary to the increasing number of GEP-NETs, GEP-
NETs of the accessory papilla of the duodenum are very 
rare. The characteristics in reported cases of GEP-NETs 
of the accessory papilla of the duodenum are demon-
strated in Table  1 [3–11]. The average tumor size was 
approximately 11  mm. Most of cases developed symp-
toms including pain, diarrhea, and weight loss. Regard-
ing the type of intervention, five cases out of ten received 
local excision with surgically (n = 4) or endoscopically 
(n = 1). Although the margin of resected tumor was con-
firmed to be positive in a case with endoscopic interven-
tion, no recurrences during the follow-up were observed 
in five cases undergoing local excision. In contrast, five 
cases underwent radical resection with pancreatoduo-
denectomy. The results of case series suggested the effi-
cacy of radical resection for the tumors. Surprisingly, 
lymph node metastases at the resected regional areas 
were identified in four cases out of five. Therefore, it 
should be recognized that GEP-NETs of the accessory 
papilla of the duodenum could metastasize to the lymph 
nodes regardless of size of the tumor.
With respect to treatment strategy, it suggests that 
pancreatoduodenectomy should be the first-line treat-
ment for GEP-NETs of the accessory papilla of the 
duodenum. In the light of malignant potential, radical 
resection should be considered even for small primary 
tumors. Minimally invasive pancreatoduodenectomy 
can be optional given the safety and oncologic efficacy of 
minimally invasive surgery [14]. In contrast, surgical or 
endoscopic local excision should not be recommended 
as curative treatment, but can be an alternative. In addi-
tion, local excision with regional lymph node dissection 
or sentinel node dissection could be an option as less 
invasive surgical intervention. Prior to performing local 
excision, accurate radiographic evaluations are important 
for localizing tumors. CT and MRI are the most common 
Fig. 2 The tumor at the accessory papilla as the accessory pancreatic duct (arrow) is shown. Hematoxylin and eosin stain demonstrating nesting 
pattern of mostly uniform cells with central ovoid nucleus (a). The lymph node metastasis (b). Synaptophysin showing positive (c). Ki-67 index stain 
showing < 1% proliferation (d)
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modalities used for evaluation of the primary tumor 
and metastasis [15]. Moreover, somatostatin receptor 
scintigraphy has improved accuracy to detect smaller 
GEP-NETs [15]. Accordingly, local excision should be 
performed only in limited cases such as high-risk patients 
for surgery or patients with no lymph node metastases. 
However, further clinicopathological evidence including 
short-term and long-term outcomes on GEP-NETs of the 
accessory papilla of the duodenum is needed.
In conclusion, we present an extremely rare case of 
GEP-NET of the accessory papilla of the duodenum 
accompanied by lymph node metastases. Although car-
cinogenic mechanism of this tumor remains uncertain 
because of the limited reports, radical resection with 
pancreatoduodenectomy should be performed due to the 
potential risks of the lymph node metastases. Minimally 
invasive approach should be considered as the alternative 
to the conventional open surgery.
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Table 1 Characteristics in reported cases of gastroenteropancreatic neuroendocrine tumors of the accessory papilla of the duodenum
M male, F female, PD pancreatoduodenectomy, LNM lymph node metastasis, NA not available
Reports (year) Age/sex Symptom Size (mm) Treatment Pathology Outcome




5–7.5 Local excision (Surgically) Somatostatinoma No recurrence, 16 months
Borobia et al. (2001) [4] 46/F Diarrhea
Steatorrhea
NA Local excision (Surgically) Neuroendocrine tumor No recurrence, 3 years





No recurrence, 6 months
Wang et al. (2005) [6] 50/M Multiple melenas
Polycythemia vera
9 Local excision (surgically) Carcinoid No recurrence, 3 years




No recurrence, 4 years






























No recurrence, 6 months
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